CRISPR THERAPEUTICS AG (CRSP)
CH0334081137 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -153.61M | -650.20M | 377.70M | -348.90M | 66.90M | |||
| Depreciation Amortization | 19.84M | 24.20M | 18.00M | 9.20M | 4.70M | |||
| Change In Working Capital | -193.59M | 19.80M | 26.90M | 33.40M | -48.40M | |||
| Other non cash items | 66.98M | 110.40M | 116.50M | 67.90M | 33.50M | |||
| OPERATING CASH FLOW | -260.38M | -495.70M | 539.00M | -238.40M | 56.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.97M | -37.20M | -81.70M | -18.40M | -6.70M | |||
| Other Investing Activity | 386.62M | -221.50M | -953.70M | -522.80M | 8.00M | |||
| INVESTING CASH FLOW | 374.65M | -258.70M | -1.04B | -541.20M | 1.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 62.66M | 38.60M | 250.90M | 1.02B | 431.00M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 62.66M | 38.60M | 250.90M | 1.02B | 431.00M | |||
| Exchange Rate Effect | 73.00K | -100.00K | 0.00 | 0.00 | 0.00 | |||
| CHANGE IN CASH | 177.01M | -715.90M | -245.50M | 236.60M | 489.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -260.38M | -495.70M | 539.00M | -238.40M | 56.70M | |||
| Capital Expenditure | -11.97M | -37.20M | -81.70M | -18.40M | -6.70M | |||
| FREE CASH FLOW | -272.35M | -532.90M | 457.30M | -256.80M | 50.00M | |||
All data in USD